Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited Stock
Equities
600329
CNE000001808
Pharmaceuticals
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
31.98 CNY | +1.11% | -0.90% | -4.96% |
Dec. 10 | Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited Announces Resignation of Wang Lei as General Manager | CI |
Nov. 27 | Tianjin Pharmaceutical Da Ren Tang Group Appoints Chair | MT |
Capitalization | 21.31B 2.94B 2.8B 2.59B 2.3B 4.16B 249B 4.61B 32.27B 11.91B 102B 11.03B 10.79B 447B | P/E ratio 2024 * |
21.7x | P/E ratio 2025 * | 18.4x |
---|---|---|---|---|---|
Enterprise value | 21.31B 2.94B 2.8B 2.59B 2.3B 4.16B 249B 4.61B 32.27B 11.91B 102B 11.03B 10.79B 447B | EV / Sales 2024 * |
2.44x | EV / Sales 2025 * | 2.23x |
Free-Float |
31.72% | Yield 2024 * |
-
| Yield 2025 * | - |
1 day | +1.11% | ||
1 week | -1.60% | ||
Current month | -0.87% | ||
1 month | -8.76% | ||
3 months | +16.55% | ||
6 months | -13.10% | ||
Current year | -4.96% |
Director | Title | Age | Since |
---|---|---|---|
Lei Wang
CEO | Chief Executive Officer | 53 | 2022-08-21 |
Jian Ma
DFI | Director of Finance/CFO | 46 | 2023-07-20 |
Hong Zhou
CTO | Chief Tech/Sci/R&D Officer | 54 | 2017-10-09 |
Manager | Title | Age | Since |
---|---|---|---|
Lei Wang
CHM | Chairman | 53 | 2024-11-25 |
Hong Zhou
BRD | Director/Board Member | 54 | 2012-11-30 |
Yoke Pheng Liew
BRD | Director/Board Member | 68 | 2020-06-04 |
Change | 5d. change | 1-year change | 3-years change | Capi. ($) | ||
---|---|---|---|---|---|---|
+1.11% | -1.60% | -7.63% | +21.32% | 2.91B | ||
+1.18% | -0.21% | +15.80% | +30.53% | 5.08B | ||
-0.18% | -2.76% | -32.12% | +1.44% | 3.9B | ||
+0.42% | -1.56% | -7.94% | +4.02% | 2.97B | ||
+0.29% | +0.18% | -3.13% | -9.17% | 2.49B | ||
-0.71% | -0.48% | -4.58% | -3.70% | 1.74B | ||
+0.32% | -2.08% | +30.33% | +61.34% | 1.68B | ||
+0.09% | -2.57% | -4.15% | -17.44% | 1.63B | ||
-1.15% | -5.06% | +65.58% | +100.86% | 1.56B | ||
+0.35% | +1.07% | -31.57% | -44.08% | 1.33B | ||
Average | +0.17% | -0.81% | +2.06% | +14.51% | 2.53B | |
Weighted average by Cap. | +0.34% | -0.54% | -0.08% | +14.97% |
2024 * | 2025 * | |
---|---|---|
Net sales | 8.72B 1.2B 1.14B 1.06B 944M 1.7B 102B 1.89B 13.21B 4.88B 41.92B 4.52B 4.42B 183B | 9.54B 1.32B 1.25B 1.16B 1.03B 1.86B 112B 2.07B 14.45B 5.34B 45.85B 4.94B 4.83B 200B |
Net income | 1.14B 157M 149M 138M 123M 222M 13.31B 246M 1.72B 636M 5.47B 589M 576M 23.85B | 1.34B 184M 175M 163M 145M 261M 15.64B 289M 2.02B 747M 6.42B 692M 677M 28.03B |
Net Debt | - | - |
Date | Price | Change | Volume |
---|---|---|---|
24-12-10 | 31.98 ¥ | +1.11% | 5,172,996 |
24-12-09 | 31.63 ¥ | -1.25% | 3,465,987 |
24-12-06 | 32.03 ¥ | +0.91% | 3,842,706 |
24-12-05 | 31.74 ¥ | -0.06% | 3,146,000 |
24-12-04 | 31.76 ¥ | -1.58% | 4,075,604 |
End-of-day quote Shanghai S.E., December 09, 2024
More quotesAnnual profits - Rate of surprise
- Stock Market
- Equities
- 600329 Stock